Skip to main content
. 2021 Jan 5;34(2):588–597. doi: 10.1007/s13577-020-00470-3

Fig. 2.

Fig. 2

MAFG-AS1 was upregulated in BC and predicted poor survival. The expression levels of MAFG-AS1 in both BC and non-tumor tissues of 66 BC patients were measured by qPCR. Experiments were repeated 3 times and mean values were presented (a). ***, p < 0.001. Survival curves were plotted for high and low MAFG-AS1 level groups (n = 32, median level of MAFG-AS1 in BC tissues as cutoff value) based on the 5-year follow-up data. Survival curves were compared by log-rank test (b)